Welcome! The Bloomington Life Sciences Partnership is a collaborative effort dedicated to continued life sciences business growth in greater Bloomington, Indiana - a nationally recognized leading metro area in medical devices, contract pharma, biotechnology, basic research and life sciences workforce development.
Cook Pharmica Grows in Monroe County
Jul20

Cook Pharmica Grows in Monroe County

BLOOMINGTON, Ind. (July 20, 2015) – Cook Pharmica, LLC, a privately-held contract development and manufacturing organization serving the biopharmaceutical industry, announced plans to expand its operations here, creating up to 70 new jobs by 2020.   The company, which is a wholly-owned subsidiary of Bloomington, Indiana-based Cook Group, will invest $28 million to renovate and equip its facility in Bloomington, which is built on the grounds of the former RCA television assembly plant. With the addition of an additional drug product line, the company will fill drug product into syringes, vials (both liquid and lyophilized) and cartridges for Cook Pharmica’s clients. Readiness activities for the new line have already begun, with plans to have the new line operating in early 2017. With its additional capacity, Cook Pharmica will better serve the growing, global biopharmaceutical industry.   “With a $59 billion economic impact in Indiana, the strength of our life sciences industry has a tremendous effect throughout the state,” said Governor Mike Pence. “Here in Indiana, we’re passionate about developing products that make our world a healthier place. We offer the business environment companies like Cook Pharmica need to thrive and in turn, create excellent jobs for Hoosiers.”   Cook Pharmica currently employs 575 associates, part of more than 13,000 Cook Group employees worldwide, and has already begun hiring for its growth. Interested applicants may apply via the careers tab on the company’s website at www.cookpharmica.com.   “Cook was founded in Bloomington more than a half century ago, and we are thrilled to continue our company’s deep connection with the state of Indiana and the city of Bloomington,” said Tedd Green, president of Cook Pharmica. “Working with our partners at the Indiana Economic Development Corporation and the city of Bloomington, this expansion will continue Cook’s commitment to providing world-class biopharmaceutical manufacturing services to customers here and around the world.”   The Indiana Economic Development Corporation offered Cook Pharmica, LLC up to $275,000 in conditional tax credits and up to $400,000 in training grants based on the company’s job creation plans. These incentives are performance-based, meaning until Hoosiers are hired, the company is not eligible to claim incentives. The city of Bloomington approved additional incentives at the request of the Bloomington Economic Development Corporation.   “Cook Pharmica is an economic force in Bloomington, attracting continued national and international recognition of our life sciences sector,” said Bloomington Mayor Mark Kruzan. “Cook Pharmica’s commitment to expansion in equipment, site improvements and workforce and the city’s support through this tax abatement will further solidify the appeal of Bloomington to a talented workforce, attract additional private sector investment and increase the awareness of Bloomington’s economic...

Read More
BioCrossroads New Venture Competition Announces 2015 Call for Entries
Jul02

BioCrossroads New Venture Competition Announces 2015 Call for Entries

BioCrossroads New Venture Competition Announces 2015 Call for Entries The BioCrossroads New Venture Competition, an early stage business competition awarding more than $60,000 in prizes to life sciences and health information technology companies, is now accepting applications at www.biocrossroads.com. Since 2012, the competition has awarded more than $180,000 to twelve start-up companies which have been able to secure nearly $7 million in follow-on funding.   Early-stage biotechnology, pharmaceutical, medical device, diagnostic, ag-biotech, and health information technology companies developing innovative products and platforms are eligible to apply for the New Venture Competition. For consideration, companies must either be Indiana-based or be able to demonstrate a significant Indiana presence.   The winner receives a cash prize of $25,000 and receives access to the Indiana Seed Fund II staff and the fund’s network of resources to provide business planning and early-stage strategic support. They will also have the opportunity to make a presentation to the ISFII investment committee. The fund has invested in several of the previous winners, collectively totaling over $1 million.   The winner will be announced at the Indiana Life Sciences Summit Innovation Capital Day on October 14, 2015 and have an opportunity to pitch their business to the conference audience. Second and third place companies will be awarded cash prizes of $15,000 and $10,000 respectively. There will also be a Pre-Venture prize of $10,000 for a promising technology that is very early in its development.   Applications are available at www.biocrossroads.com and must be submitted by August 17, 2015. Companies invited to the next round will be notified by August 28 and must submit their pitch deck by September 11, 2015. Presentations will be held from September 14-18, 2015. The finalists will then present to a panel of expert judges before the Indiana Life Sciences Summit on Wednesday, Oct. 14.   Previous Winners include: Anagin, Dianotes, and Spensa...

Read More
Cook Medical welcomes progressive Medical Device Single Audit Program
Jun16

Cook Medical welcomes progressive Medical Device Single Audit Program

Bloomington, Ind. — Cook Medical is pleased to be one of the global medical device companies to collaborate internationally with regulatory authorities on the Medical Device Single Audit Program (MDSAP).   The value of developing a global program to audit and monitor medical device manufacturing for patient safety was recognized at the International Medical Device Regulators Forum inaugural meeting in 2012. That meeting led to the creation of MDSAP.   MDSAP International Coalition Organizations: US Food and Drug Administration (FDA) Health Canada Therapeutics Goods Administration (TGA) Australia Agência Nacional de Vigilância Sanitária (ANVISA) Brazil Ministry of Health, Labour and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) Japan   “This progressive approach to regulatory oversight is very exciting,” said Pete Yonkman, president of Cook Medical. “We recognize that good collaboration among regulatory agencies and industry enables more efficient and flexible use of both regulatory and company resources.”   The MDSAP enables regulatory oversight of manufacturers’ quality management systems while minimizing the regulatory burden on industry. It also promotes more efficient and flexible use of regulatory resources through work sharing and mutual acceptance among regulators while respecting the sovereignty of each authority. It also leverages, where appropriate, existing conformity assessment structures.   The Cook Medical plant in Limerick, Ireland, was chosen to trial this new auditing approach. The facility, which employs over 800 staff, underwent a two-day initial certification audit in April, which was led by TÜV SÜD of Germany. It is the first Irish site to take part in MDSAP. This audit is one of six global MDSAP audits to date.   About the Medical Device Single Audit Program: It is based on a three-year audit cycle. The initial certification audit constitutes a stage-one and stage-two audit of a quality management system. A partial surveillance audit takes place in each of the following two years. A complete recertification audit is performed after three years. About Cook Medical Since 1963 Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities. Find out more at www.cookmedical.com, and for the latest news, follow us on Twitter and LinkedIn.   Source: Cook...

Read More
Indiana Biosciences Research Institute Names CEO
May22

Indiana Biosciences Research Institute Names CEO

David Broecker Named CEO of Indiana Biosciences Research Institute   Nationally Recognized Real Estate Developer – Wexford Science and Technology – Chosen to Lead Development Activities David Broecker The Indiana Biosciences Research Institute (IBRI) announces the appointment of David A. Broecker, a prominent life sciences industry executive and serial entrepreneur, as the Institute’s president and chief executive officer, and the selection of Wexford Science and Technology as the real estate development firm to lead site selection and development activities.   After serving most recently as president and chief operating officer, Broecker will now accelerate activities as president and CEO to advance the Institute’s mission, select a permanent home, secure key research recruitments, build a seasoned operations team and launch the IBRI’s first collaborative research initiatives in 2015.   “As our Board moves forward with creating the IBRI, it is increasingly clear that we need a CEO who truly covers all the bases, with the experience and the passion to build a world-class research institute in collaboration with our diverse and deeply committed array of industry and academic stakeholders,” said David L. Johnson, IBRI board member and president and CEO of BioCrossroads, which has facilitated the Institute’s early development. “We are fortunate indeed that David Broecker has returned home to Indiana and has enthusiastically accepted our appointment. There is no one in the country today better suited to deliver on the pioneering mission and immense promise of the Indiana Biosciences Research Institute,” Johnson added.   Click here for the full press...

Read More
IU, IU Health Bloomington Hospital Announce New Health Complex
Apr15

IU, IU Health Bloomington Hospital Announce New Health Complex

Agreement outlines regional academic health campus and new IU Health Bloomington hospital location     Bloomington, Ind. – Indiana University, IU Health and IU Health Bloomington Hospital today announced they have reached an agreement to create a regional academic health center in Bloomington, which will include a new home for IU Health Bloomington Hospital.   The centerpiece of the project, announced this morning on the IU Bloomington campus, is the decision to locate IU Health Bloomington Hospital on the current site of the IU golf driving range on 75 acres just off the SR 45/46 bypass adjacent to the IU Technology Park.   “This is an incredibly exciting time in our hospital’s history. This collaboration will provide many benefits for our community, our hospital and IU,” says Mark Moore, President of IU Health Bloomington Hospital and the South Central Region. “We’ve been working with the community in Bloomington to determine how best to serve and deliver value to our fellow citizens, and this plan provides an extraordinary solution for meeting the emerging healthcare needs of the region,” he said. “This synergism will create tremendous opportunity for all parties concerned and especially our patients.”   Dan Evans, president and CEO of IU Health, said the project will strengthen the impact of IU Health’s tripartite mission in southern  Indiana.   “The creation of a regional academic health campus in Bloomington increases our ability to improve patient care by providing more opportunities for collaboration among our clinical, research and medical staff and faculty. It strengthens our partnership with the IU School of Medicine and our ability to develop a robust research program to bring more clinical trials and innovative treatment methods to the people of southern Indiana and beyond,” he said.   Though still in the early planning stages, the proposed health complex is expected to employ thousands, not only in construction positions but also in patient care and support services. It also will allow IU to expand its medical education programs and research opportunities on the Bloomington campus to keep up with increasing demand for practical experience from students in health-related disciplines, especially social work, nursing, hearing and speech therapy and dentistry.   “This is a momentous moment for Indiana University and IU Health – and for the city of Bloomington,” said Indiana University President Michael A. McRobbie. “This plan will lead to the creation of the most comprehensive academic health campus in the state outside of Indianapolis and will bring together most of the IU Bloomington health science programs, and possibly additional programs, into one place co-located with the new IU Bloomington Hospital. This will considerably expand the opportunities for health...

Read More